Benjamin E. Onderdonk
YOU?
Author Swipe
View article: Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases Open
BACKGROUNDWe previously demonstrated the safety of stereotactic body radiotherapy followed by pembrolizumab (SBRT+P) in patients with advanced solid tumors. This phase I clinical trial was expanded to study the safety of partial tumor irra…
View article: Data from Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial
Data from Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial Open
Purpose:Multisite stereotactic body radiotherapy followed by pembrolizumab (SBRT+P) has demonstrated safety in advanced solid tumors (ASTs). However, no studies have examined the relationships between irradiated tumor response, SBRT-induce…
View article: Supplementary Data from Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial
Supplementary Data from Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial Open
Supplemental Methods, Figures, and Tables
View article: Supplementary Data from Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial
Supplementary Data from Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial Open
Supplemental Methods, Figures, and Tables
View article: Data from Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial
Data from Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial Open
Purpose:Multisite stereotactic body radiotherapy followed by pembrolizumab (SBRT+P) has demonstrated safety in advanced solid tumors (ASTs). However, no studies have examined the relationships between irradiated tumor response, SBRT-induce…
View article: A prospective clinical and transcriptomic feasibility study of oral‐only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity
A prospective clinical and transcriptomic feasibility study of oral‐only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity Open
BACKGROUND Androgen deprivation therapy (ADT) improves outcomes in unfavorable‐risk prostate cancer (PCa) treated with radiation therapy (RT). It was hypothesized that replacing luteinizing hormone‐releasing hormone (LHRH) agonists with a …
View article: Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial Open
Purpose: Multisite stereotactic body radiotherapy followed by pembrolizumab (SBRT+P) has demonstrated safety in advanced solid tumors (ASTs). However, no studies have examined the relationships between irradiated tumor response, SBRT-induc…
View article: Adjuvant treatment for high‐risk salivary gland malignancies and prognostic stratification based on a 20‐year single institution experience
Adjuvant treatment for high‐risk salivary gland malignancies and prognostic stratification based on a 20‐year single institution experience Open
Background and Aim Retrospective analysis of the utility of adjuvant radiation (RT) or chemoradiation (CRT) and identify prognostic features for patients with high‐risk head and neck salivary gland cancers. Methods From 1/1997 to 12/2017, …
View article: The clinical utility of imaging methods used to measure hypoxia in cervical cancer
The clinical utility of imaging methods used to measure hypoxia in cervical cancer Open
While it is well-established that hypoxia is a major factor that affects clinical outcomes in cervical cancer, widespread usage of clinically available methods to detect and evaluate hypoxia during the course of treatment have not been est…
View article: The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond Open
Background: Oligometastatic disease has emerged as a possibly distinct metastatic phenotype in numerous cancer histologies. With the advancement in treatment modalities including stereotactic body radiation therapy (SBRT), certain patients…
View article: Metastatic lung carcinoma presenting as intussusception of the ascending colon
Metastatic lung carcinoma presenting as intussusception of the ascending colon Open
Introduction: Lung cancer remains a leading cause of cancer deaths worldwide, and an estimated 50% of cases are associated with metastasis at the time of diagnosis. We present the case of a 45-year-old female smoker with a history of right…
View article: Institutional experience using interstitial brachytherapy for the treatment of primary and recurrent pelvic malignancies
Institutional experience using interstitial brachytherapy for the treatment of primary and recurrent pelvic malignancies Open
AMA Aridgides P, Onderdonk B, Cunningham M, et al. Institutional experience using interstitial brachytherapy for the treatment of primary and recurrent pelvic malignancies. Journal of Contemporary Brachytherapy. 2016;8(3):173-180. doi:10.5…